RIPPLE
LIVE

Serial Number

99348403

Owner

SonoThera, Inc.

Attorney

Dustin Luettgen

Filing Date

Aug 20, 2025

Add to watchlist:

No watchlists yet
View on USPTO

RIPPLE Trademark

Serial Number: 99348403

RIPPLE is a trademark filed by SonoThera, Inc. on August 20, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

SonoThera, Inc. (7 trademarks)

201 Haskins Way
South San Francisco, CA 94080

Entity Type: 03

Trademark Details

Filing Date

August 20, 2025

Registration Date

Not Registered

Goods & Services

Software for operation of ultrasound systems and ultrasound probes for administration of pharmaceutical agents, namely, biological preparations for the treatment of human diseases or disorders and gene therapy preparations

Software as a service for the operation of ultrasound systems and ultrasound probes for administration of pharmaceutical agents, namely, biological preparations for the treatment of human diseases or disorders and gene therapy preparations; Research and development in the field of gene therapy

Gene therapy preparations, namely, biological preparations for the treatment of human diseases or disorders, namely, diseases of genetic or genetic predisposition etiology; kits comprised of gene therapies, namely, biological preparations and pharmaceutical preparations both for the treatment of human diseases and disorders, namely, diseases of genetic or genetic predisposition etiology; gene delivery platform, namely, biological delivery agents for the treatment of human diseases and disorders, namely, diseases of genetic or genetic predisposition etiology

Medical services for ultrasound mediated administration of pharmaceutical agents, namely, biological preparations for the treatment of human diseases or disorders and gene therapy preparations

Ultrasound systems and ultrasound probes for administration of pharmaceutical agents, namely, biological preparations for the treatment of human diseases or disorders and gene therapy preparations

Filing History

NOTIFICATION OF PRIORITY ACTION E-MAILED
Jan 7, 2026 GPRN
PRIORITY ACTION E-MAILED
Jan 7, 2026 GPRA
PRIORITY ACTION WRITTEN
Jan 7, 2026 CPRA
ASSIGNED TO EXAMINER
Jan 6, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 20, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 20, 2025 NWOS
NEW APPLICATION ENTERED
Aug 20, 2025 NWAP